2m 2m 2m 2m 2m 2m 2m
CENTURY THERAP (IPSC)
NASDAQ
$1.58-$0.03 (-1.86%)
Price as of Oct 22, 2026 7:30 PM EDT- $291.5MMarket Cap
- 185.97%1-Year Change
- BiotechnologyIndustry
CENTURY THERAP (IPSC)
$1.58-$0.03 (-1.86%)
IPSC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.61 | ||
Change | -$0.03 (-1.83%) | ||
Open | $1.65 | ||
High | $1.67 | ||
Low | $1.52 | ||
Previous Close | $1.64 | ||
Volume | 1,645,276 | ||
30-Day Average Volume | 834,921 | ||
1-Week Change | 16.67% | ||
1-Month Change | -12.97% | ||
1-Year Change | 185.97% | ||
3-Year Change | 8.78% | ||
5-Year Change | -91.89% | ||
Fundamentals | |||
Shares Outstanding | 181.1M | ||
Total Assets | $287.0M | ||
Market Cap | $291.5M | ||
Enterprise Value | $241.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.5M | ||
Free Cash Flow | -$20.5M | ||
EBIT | -$34.5M | ||
EBITDA | -$31.9M | ||
Net Working Capital | $109.7M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue